None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients visited Asan medical center due to upper gastrointestinal disease who underwent gastroscopy (aged 18-80 ). 2) A patient who voluntarily signed a written informed consent after being fully explained about this clinical trial.
Exclusion criteria
Exclusion criteria: 1) Patients who have coagulopathy (Platelet <50K , PT< 60% , aspirin/warfarin ) 2) Patients who did not consent to or withdrew consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the accuracy of the rapid urease assay according to the sample collection site based on the positive rate of pathological immunostaining. | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy evaluation of rapid urease test according to sample collection site according to OLGA and OLGIM stages | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center